Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ISOLOTCMKTS:OCQLFOTCMKTS:RETCOTCMKTS:SPZR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISOL1mage Software$0.00$0.00$0.00▼$0.00N/A3.84N/AN/AOCQLF01 Communique Laboratory$0.28+0.9%$0.24$0.05▼$0.22N/AN/A5,680 shs114,181 shsRETC12 Retech$0.00$0.00▼$0.00N/AN/AN/AN/ASPZREnveric Biosciences$0.00$0.03▼$0.17N/AN/A12,294 shsN/A10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISOL1mage Software0.00%0.00%0.00%-81.82%-80.00%OCQLF01 Communique Laboratory0.00%-1.76%+21.37%+39.70%+709.86%RETC12 Retech0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationISOL1mage SoftwareN/AN/AN/AN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/AN/AN/AN/ARETC12 RetechN/AN/AN/AN/AN/AN/AN/AN/ASPZREnveric BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISOL1mage Software 0.00N/AN/AN/AOCQLF01 Communique Laboratory 0.00N/AN/AN/ARETC12 Retech 0.00N/AN/AN/ASPZREnveric Biosciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISOL1mage SoftwareN/AN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/AN/ARETC12 RetechN/AN/AN/AN/AN/AN/ASPZREnveric BiosciencesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISOL1mage SoftwareN/AN/A0.00∞N/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/A0.00∞N/AN/AN/AN/AN/ARETC12 RetechN/AN/A0.00N/AN/AN/AN/AN/AN/ASPZREnveric BiosciencesN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISOL1mage SoftwareN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/ARETC12 RetechN/AN/AN/AN/AN/ASPZREnveric BiosciencesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISOL1mage SoftwareN/AOCQLF01 Communique LaboratoryN/ARETC12 RetechN/ASPZREnveric BiosciencesN/AInsider OwnershipCompanyInsider OwnershipISOL1mage Software52.80%OCQLF01 Communique LaboratoryN/ARETC12 RetechN/ASPZREnveric BiosciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISOL1mage Software13N/AN/ANot OptionableOCQLF01 Communique LaboratoryN/AN/AN/ANot OptionableRETC12 Retech4N/AN/ANot OptionableSPZREnveric BiosciencesN/AN/AN/ANot OptionableSPZR, OCQLF, RETC, and ISOL HeadlinesRecent News About These CompaniesEnveric Receives U.S. Patent for Sleep, CNS TherapeuticsJune 4, 2025 | insidermonkey.comEnveric’s EB-003 shows statistically significant improvements in model of severe chronic depressionMay 30, 2025 | bioworld.comBPsychedelic: Enveric, Filament Health report earnings resultsApril 3, 2025 | markets.businessinsider.comEnveric Biosciences reports $3.2M net loss in Q4March 31, 2025 | gulfshorebusiness.comGEnveric posts $9.5M loss for 2024, but revenue could be on horizon with licensing dealsMarch 31, 2025 | greenmarketreport.comGEnveric Biosciences Participating in BIO-Europe Spring®March 17, 2025 | financialpost.comFEnveric Biosciences Participating in BIO-Europe Spring®March 17, 2025 | financialpost.comFEnveric Biosciences, Inc. (ENVB) Seeks Buyers for PsyAI Trademark Amid Shift to Neuroplastogen DevelopmentMarch 7, 2025 | insidermonkey.comEnveric Biosciences, Inc. (ENVB) Seeks Buyers for PsyAI Trademark Amid Shift to Neuroplastogen DevelopmentMarch 7, 2025 | msn.comEnveric CEO says company is ‘at the forefront’ of neuroplastogens fieldFebruary 27, 2025 | msn.comWhat’s Causing Enveric Biosciences Inc (ENVB) Stock’s -79.65% Drop Over the Last Six Months?February 5, 2025 | bovnews.comBEnveric Passes Key Milestone on Patent Path for Mental-Health TreatmentJanuary 30, 2025 | marketwatch.comEnveric Biosciences gets Notice of Allowance for EB-003 from USPTOJanuary 30, 2025 | markets.businessinsider.comEnveric Biosciences 1.67M share Spot Secondary priced at $3.00January 30, 2025 | markets.businessinsider.comEnveric Biosciences stock hits 52-week low at $0.29January 28, 2025 | msn.comEnveric Biosciences trading halted, news pendingJanuary 25, 2025 | markets.businessinsider.comEnveric Biosciences Announces 1-for-15 Reverse Stock SplitJanuary 21, 2025 | msn.comEnveric Biosciences to Release Investor PresentationJanuary 3, 2025 | tipranks.comEnveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like BehaviorNovember 25, 2024 | financialpost.comFEnveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like BehaviorNovember 25, 2024 | financialpost.comFMedia Sentiment Over TimeSPZR, OCQLF, RETC, and ISOL Company Descriptions1mage Software OTCMKTS:ISOL$0.0002 0.00 (0.00%) As of 06/27/20251mage Software Inc operates in the technology industry. The company offers capturing services, including 1ACCESS, an java-based software application that utilizes the adobe PDF format, which could be printed, faxed, and emailed; application program interfaces consisting of executable subroutines; 1FAX, an software application that manages inbound/outbound fax transmissions and outbound emails; 1SCAN, a windows based software application; and 1ERM that provides simultaneous and multi-user access to indexed and archived computer-generated reports and customer-related documents. Its capturing services also include 1SCANSERV, which allow scanned documents from an MFP or a scanner to be transformed into image files; V1A, a document imaging software that allows viewing images; and Zoë, which gives access to other outside applications. The company also provides integrating services, such as application program interfaces; Zoë that gives access to other outside applications; ZoëFetch, an application bridge, which works with various applications; and Zoë XML Web services that allows users to seamlessly integrate with line of business application. In addition, it offers archiving services; and digital content management system that provides solutions for the scanning, indexing, storing, and retrieving of document images. Further, the company provides 1SEARCH that locate and retrieve documents/images, as well as Web services. Additionally, it offers exporting services, which include 1PUBLISH that enables users with specific security rights; and 1RENDITION, which automates the rendition billing process. The company is based in Centennial, Colorado.01 Communique Laboratory OTCMKTS:OCQLF$0.28 +0.00 (+0.90%) As of 06/27/202501 Communique Laboratory, Inc. develops and markets remote access solutions. The Company's solutions consist of I'm InTouch, I'm OnCall and I'm InTouch Meeting product lines, which provide users with the ability to conduct online meetings. 01 Communique Laboratory was founded on October 7, 1992 and is headquartered in Toronto, Canada.12 Retech OTCMKTS:RETC12 ReTech Corporation, together with its subsidiaries, develops, installs, and sells software for retailers in the United States. Its platform includes 12Mirror, an in-store application, which recognizes clothes worn by a person in reflection and takes pictures that are downloadable by the user and sharable through social media; 12Kiosk, an in-store application, which is used for browsing and obtaining information about consumers and products, as well as placing orders and checking out; 12Mobile, a mobile app that is used for browse products, place orders, and share products with other members and make new friends; and 12Desktop, an e-commerce website. The company also operates retail stores in airport terminals and casinos under the Bluwire brand; sells fashionable apparel under the Rune NYC, Social Sunday, and Red Wire Design brands; and produces women's clothing products. 12 ReTech Corporation was founded in 2014 and is based in Phoenix, Arizona.Enveric Biosciences OTCMKTS:SPZREnveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
